Demystifying the immune system with the help of AI-ML
Demystifying the immune system with the help of AI-ML
Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s Keytruda (pembrolizumab) and BMS’s Opdivo (nivolumab) generating billions in annual revenue since their US Food and Drug Administration (FDA) approval in 2014.
